Glycemic control among People living with HIV and diabetes in Eastern Uganda: A cross-sectional study
Main Article Content
Keywords
People living with HIV and diabetes, Glycemic control, Eastern Uganda
Abstract
Background: Poor glycemic control remains a significant Public Health problem among people living with HIV(PLWH) and diabetes in Africa and Uganda specifically. Dual diagnosis of HIV and diabetes is associated with high costs of management and poor prognosis. This study aimed to determine the baseline glycemic control of PLWH and diabetes and associated factors in Eastern Uganda.
Methodology: This study employed quantitative methods along with a cross-sectional analytical study design. A total of 257 participants (ten didn’t participate) from Mbale and Soroti Regional Referral Hospitals participated in this study from May 1 to July 30th, 2024. The sample size was determined using the modified Cochrane formula, and participants were selected using simple random sampling. An electronic questionnaire was used to collect socio-demographic and clinical data. An automated Finecare HbA1c analyser was used to determine the HbA1c levels of participants. The data was analysed using Stata version 15. Multivariable logistic regression analyses were conducted to identify associated factors. At p<0.05, statistical significance was established.
Results: The median age was 51(44, 60). The female participants comprised 152 (59.1%), and 52 (20.2%) of the total participants had a tertiary education. More than half, 136 (52.9%), had HbA1c above 7%. The age group above 50 years, having more than three children, and tertiary education were positively associated; however, only the tertiary level of education was statistically significant after adjusting for confounders, aPOR 3.9(95% CI:1.1-14.2), p=0.037.
Conclusion: The prevalence of poor glycemic control among people living with HIV and diabetes at Mbale and Soroti Hospitals in Uganda is high at 52.90%. The age group above 50 years, having children and tertiary education were positively associated with poor glycemic control. Routine HbA1c testing and immediate evidence-based management by health workers are encouraged among clients over 50, those with children, and those with tertiary education.
References
2. Peer N, Nguyen KA, Hill J, Sumner AE, Cikomola JC, Nachega JB, et al. Prevalence and influences of diabetes and prediabetes among adults living with HIV in Africa: a systematic review and meta-analysis. J Int AIDS Soc. 2023;26(3):1–27.
3. Rwegerera GM, Shailemo DHP, Pina Rivera Y, Mokgosi KO, Bale P, Oyewo TA, et al. Metabolic Control and Determinants Among HIV-Infected Type 2 Diabetes Mellitus Patients Attending a Tertiary Clinic in Botswana. Diabetes Metab Syndr Obes. 2021;14:85 97.
4. Ssentongo J, Tumwine G, Nabirye S, Kokas I. Diabetes among HIV-Infected Patients on Antiretroviral Therapy at Mulago National Referral Hospital in Central Uganda. 2024;(August 2019).
5. Rajagopaul A, Naidoo M. Prevalence of diabetes mellitus and hypertension amongst the HIV-positive population at a district hospital in eThekwini, South Africa. African J Prim Heal Care Fam Med. 2021;13(1):1–6.
6. Ssentongo J, Tumwine G, Nabirye S, Kokas I. Diabetes among HIV-Infected Patients on Antiretroviral Therapy at Mulago National Referral Hospital in Central Uganda. Int J Innov Sci Res Technol [Internet]. 2019;4(8). Available from: www.ijisrt.com
7. Mulindwa F, Castelnuovo B, Brusselaers N, Nabwana M, Bollinger R, Buzibye A, et al. Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults. AIDS Res Ther. 2023 Sep;20(1):65.
8. Monroe AK, Glesby MJ, Brown TT. Diagnosing and Managing Diabetes in HIV-Infected Patients: Current Concepts. Clin Infect Dis [Internet]. 2015 Feb 1;60(3):453–62. Available from: https://doi.org/10.1093/cid/ciu779
9. Bitew ZW, Alemu A, Jember DA, Tadesse E, Getaneh FB, Sied A, et al. Prevalence of Glycemic Control and Factors Associated With Poor Glycemic Control: A Systematic Review and Meta-analysis. Inquiry. 2023;60:469580231155716.
10. Gerber A, Fischetti B, Popova O, Longo M. Glycemic Control in Patients Living With HIV Initiated on Integrase Inhibitor-Based Three-Drug Antiretroviral Therapy. J Pharm Technol jPT Off Publ Assoc Pharm Tech. 2024 Apr;40(2):85–91.
11. Dawson AZ, Walker RJ, Egede LE. Differential Relationships Between Diabetes Knowledge Scales and Diabetes Outcomes. Diabetes Educ. 2017 Aug;43(4):360–6.
12. Patrick NB, Yadesa TM, Muhindo R. Poor Glycemic Control and the Contributing Factors Among Type 2 Diabetes Mellitus Patients Attending Outpatient Diabetes Clinic at Mbarara Regional Referral Hospital , Uganda Poor Glycemic Control and the Contributing Factors Among Type 2 Diabetes Mellitu. 2021;
13. Azagew AW, Mekonnen CK, Lambie M, Shepherd T, Babatunde OO. Poor glycemic control and its predictors among people living with diabetes in low ‑ and middle ‑ income countries : a systematic review and meta ‑ analysis. BMC Public Health [Internet]. 2025; Available from: https://doi.org/10.1186/s12889-025-21828-y
14. Byereta LH, Olum R, Mutebi EI, Kalyesubula R, Kagimu M, Meya DB, et al. Prevalence and factors associated with hyperglycemia among persons living with HIV / AIDS on dolutegravir-based antiretroviral therapy in Uganda. 2024;1–14.
15. Berhan D, Deshimo G, Id L, Gebeyaw ED. Diabetes knowledge and glycemic control among type 2 diabetes patients at public. 2025;9:1–11. Available from: http://dx.doi.org/10.1371/journal.pone.0317288
16. Baker S, Id O, Kiyimba K, Napyo A, Kanyike AM, Mayoka WJ, et al. Appropriateness and affordability of prescriptions to diabetic patients attending a tertiary hospital in Eastern Uganda : A retrospective cross-sectional study. 2021;1–12. Available from: http://dx.doi.org/10.1371/journal.pone.0245036
17. Anaya-Ambriz EJ, Alvarez-Zavala M, González-Hernández LA, Andrade-Villanueva JF, Zuñiga-Quiñones S, Valle-Rodríguez A, et al. Deciphering the Association: Critical HDL-C Levels and Their Impact on the Glycation Gap in People Living with HIV. Int J Mol Sci [Internet]. 2025;26(3). Available from: https://www.mdpi.com/1422-0067/26/3/914
18. Njuguna B, Kiplagat J, Bloomfield GS, Pastakia SD, Vedanthan R, Koethe JR. Prevalence, Risk Factors, and Pathophysiology of Dysglycemia among People Living with HIV in Sub-Saharan Africa. J Diabetes Res. 2018;2018:6916497.
19. Burgess PI, Harding SP, Kayange PC, van Oosterhout J, García-Fiñana M, Msukwa G, et al. High mortality in subjects with both diabetes and HIV in sub-Saharan Africa. Vol. 32, AIDS (London, England). England; 2018. p. 2083–4.
20. Tegegne KD, Gebeyehu NA, Yirdaw LT, Yitayew YA, Kassaw MW. Determinants of poor glycemic control among type 2 diabetes in Ethiopia: a systematic review and meta-analysis. Front public Heal. 2024;12:1256024.
21. Iradukunda A, Kembabazi S, Ssewante N, Kazibwe A, Kabakambira JD. Diabetic Complications and Associated Factors: A 5-Year Facility-Based Retrospective Study at a Tertiary Hospital in Rwanda. Diabetes Metab Syndr Obes. 2021;14:4801–10.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.